SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-057449
Filing Date
2017-11-09
Accepted
2017-11-09 08:31:10
Documents
44
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv478531_10q.htm 10-Q 565935
2 EXHIBIT 31.1 tv478531_ex31-1.htm EX-31.1 9564
3 EXHIBIT 31.2 tv478531_ex31-2.htm EX-31.2 8889
4 EXHIBIT 32.1 tv478531_ex32-1.htm EX-32.1 4070
5 EXHIBIT 32.2 tv478531_ex32-2.htm EX-32.2 3976
  Complete submission text file 0001144204-17-057449.txt   2851562

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atxi-20170930.xml EX-101.INS 456198
7 XBRL TAXONOMY EXTENSION SCHEMA atxi-20170930.xsd EX-101.SCH 26047
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20170930_cal.xml EX-101.CAL 23994
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20170930_def.xml EX-101.DEF 186484
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20170930_lab.xml EX-101.LAB 208446
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20170930_pre.xml EX-101.PRE 219164
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 171188383
SIC: 2834 Pharmaceutical Preparations